N. Khin

Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop

N. Khin, G. Francis, Jean Mulinde, 2020 .

Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA Perspective

R. O’Neill, S‐M Huang, R. Temple, 2013, Clinical pharmacology and therapeutics.

Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.

N. Khin, Yeh-Fong Chen, Peiling Yang, 2012, The Journal of clinical psychiatry.

Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials.

W. Horan, J. Geraci, F. Butlen-Ducuing, 2022, Innovations in clinical neuroscience.

Brain reactive monoclonal auto-antibodies: Production and characterization

N. Khin, S. A. Hoffman, N. A. Khin, 1993, Journal of Neuroimmunology.

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

N. Khin, Yeh-Fong Chen, Peiling Yang, 2011, The Journal of clinical psychiatry.

Trial design issues and treatment effect modeling in multi‐regional schizophrenia trials

H M James Hung, Sue-Jane Wang, Yeh-Fong Chen, 2010, Pharmaceutical statistics.